InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,320.40
(
0.12%
)
Dow Jones
42,063.36
(
0.00%
)
Brent Oil
73.85
(
-0.05%
)
Bitcoin
63,384.43
(
-0.37%
)
Post# of 58465
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

STOCK_GAINER6

Send PM Follow Ignore
Followers 22
Posts 2010
Boards Moderated 0
Alias Born 04/07/2011

STOCK_GAINER6

Re: None

Thursday, 06/12/2014 10:23:56 AM

Thursday, June 12, 2014 10:23:56 AM

Post# of 58465
Genta has also a long and outstanding history in the use of gallium compounds as use in a pharmaceutical preparation. Raymond Warrel, CEO of Genta, has an excepional background in the use of gallium compounds in the treatment of bone cancer associated hypercalcemia.

A profile of him and some of his publications are give at the web site of his current employer:
http://relburn.com/raymond-warrell/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up